Efficacy and safety of evogliptin in patients with type 2 diabetes and non-alcoholic fatty liver disease: A multicentre, double-blind, randomized, comparative trial

Affiliations

• ¹ Division of Endocrinology and Metabolism, Department of Internal Medicine, Keimyung University School of Medicine, Daegu, South Korea.
• ² Division of Endocrinology and Metabolism, Department of Internal Medicine, Hallym University Sacred Heart Hospital, Anyang, South Korea.
• ³ Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea.
• ⁴ Division of Endocrinology and Metabolism, Department of Internal Medicine, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, South Korea.
• ⁵ Division of Endocrinology and Metabolism, Department of Internal Medicine, Soonchunhyang University Cheonan Hospital, Cheonan, South Korea.
• ⁶ Division of Endocrinology and Metabolism, Department of Internal Medicine, College of Medicine, Hanyang University, Seoul, South Korea.
• ⁷ Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul National University, Seoul, South Korea.
• ⁸ Division of Endocrinology and Metabolism, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea.
• ⁹ Institute of Endocrine Research, Yonsei University College of Medicine, Seoul, South Korea.